Early dynamic magnetic resonance imaging of liver metastases with 0.3 and 0.6 mmol/kg gadoteridol injection

Investigative Radiology

Volumn 31, Issue 8, 1996, Pages 472-478

  Runge, Val M ^a   Wells, John W ^a   Williams, Neil M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

contrast enhancement; gadolinium; liver; liver neoplasms; Magnetic resonance; metastasis

Indexed keywords

GADOLINIUM; GADOTERIDOL;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LIVER PARENCHYMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

EID: 0029764339     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199608000-00002     Document Type: Article

References (15)

1. Ferrucci JT. Liver tumor imaging: Current concepts. Radiol Clin North Am 1994 32:39-54.
2. Mirowitz SA, Lee JKT, Gutierreze E, et al. Dynamic gadolinium enhanced rapid acquisition spin echo MR imaging of the liver. Radiology 1991;179:371-376.
3. Carr DH, Graif M, Niendorf HP, et al. Gadolinium DTPA in the assessment of liver tumours by magnetic resonance imaging. Clin Radiol 1986;37:347-353.
4. Runge VM, Kirsch JE, Woolfolk C, et al. Gadoteridol dose dependence in MR imaging of a liver abscess model. J Magn Reson Imaging 1994;4:343-350.
5. Mitchell DG, Saini S, Weinreb J, et al. Hepatic metastases and cavernous hemangiomas: Distinction with standard and triple dose gadoteridol enhanced MR imaging. Radiology 1994;193: 49-57.
6. Wedeking P, Sotak CH, Telser J, et al. Quantitative dependence of MR signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat. J Magn Reson Imaging 1992;10:97-108.
7. Edelman RR, Siegel JB, Singer A, et al. Dynamic MR imaging of the liver with Gd DTPA: Initial clinical results. AJR Am J Roentgenol 1989;153:1213-1219.
8. Soyer P, Levesque M, Caudron C, et al. MRI of liver metastases from colorectal cancer vs. CT during arterial portography. J Comput Assist Tomogr 1993;17:67-74.
9. Ito K, Choji T, Nakada T, et al. Multislice dynamic MRI of hepatic tumors. J Comput Assist Tomogr 1993;17:390-396.
10. Low RN, Francis IR, Sigeti JS, Foo TKF. Abdominal MR imaging: Comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging. Radiology 1993;186:803-811.
11. Runge VM, Pels Rijcken TH, Davidoff A, et al. Contrast-enhanced MR imaging of the liver. J Magn Reson Imaging 1994;4:281-289.
12. Runge VM, Kirsch JE, Wells, JW, et al. Enhanced liver MR: Contrast agents and imaging strategy. Crit Rev Diagn Imaging 1993;34:1-30.
13. Kreft BP, Tanimoto A, Stark DD, et al. Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats. J Magn Reson Imagimg 1993;3:41-49.
14. Rosati G, Pirovano G, Spinazzi A. Interim results of phase II clinical testing of gadobenate dimeglumine. Invest Radiol 1994;29(suppl 2):S183-S185.
15. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-792.